Navigation Links
Astellas and Gift of Hope Organ & Tissue Donor Network Join Forces to Raise Awareness of Need for More Organ Donors in Chicago
Date:4/19/2013

NORTHBROOK, Ill., April 19, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), and Gift of Hope Organ & Tissue Donor Network, a not-for-profit organ procurement organization that coordinates organ and tissue donation and provides public education on donation in Illinois and northwest Indiana, have collaborated to raise awareness of the need for more organ donors in the city of Chicago. As part of the efforts, Mayor Rahm Emanuel signed a proclamation declaring today, April 19, Organ Donation Awareness Day in the city of Chicago. Astellas and Gift of Hope are encouraging the Chicago community to learn more about organ donation, and register their decision to donate.

"We're proud to partner with Astellas in building a community of support around organ donation awareness and the need for more donors," said David Bosch , Director of Communications and Legislative Affairs at Gift of Hope. "The decision to be an organ donor gives hope to many people awaiting a second chance."

While organ transplantation is a remarkable story in the history of medicine, the need for organs is vastly greater than the number available for transplantation. Currently there are more than 117,000 people in the U.S. awaiting an organ transplant – including more than 5,000 people in Illinois. Each year, more than 28,000 Americans receive a donated organ, but sadly, more than 6,500 people die each year waiting for an organ.

Today's proclamation underscores Astellas' ongoing commitment to the Chicago community, as well as the national tran
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure
2. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
3. PGA TOUR Celebrates Official Launch of the Astellas Presents Executive Womens Day Program
4. Astellas to Drive PGA TOURs New Womens Initiative
5. Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
6. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
7. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
8. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
9. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
10. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
11. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ... the development and commercialization of innovative therapies for the ... PDUFA date for Zalviso remains July 27, 2014.  ... online stating the Food and Drug Administration (FDA) had ... been no notification to the company from the FDA ...
(Date:7/24/2014)... HILDEN , Germany , and ... , Exclusive global ... assays for SF3B1 mutations, including next-generation sequencing (NGS) gene ... gene, to be targeted by new test, indicate favorable ... myelodysplastic syndromes  QIAGEN sees potential for developing ...
(Date:7/24/2014)... -- Amgen (NASDAQ: AMGN ) today announced that ... July 29, 2014, after the close of the U.S. financial ... with the investment community at 2 p.m. PT. Participating in ... , chairman and chief executive officer, and other members of ... conference call will be simultaneously broadcast over the Internet and ...
Breaking Medicine Technology:AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
...  The advanced functionality of Elekta,s family of digital ... coordination. Elekta,s latest control system, Integrity™ R1.1, meets ... of MLC interdigitation for exceptional field shaping, and ... radiation dose. Integrity ...
... Inc. (NASDAQ: VSCP ), a leading provider of ... Markin, the company,s president and chief executive officer, will be ... CEO & Investor Conference at the Waldorf Astoria in New ... 13, 2012 at 4:30 PM ET. A live ...
Cached Medicine Technology:Sixth Generation Elekta Digital Control System Boosts Radiation Therapy System Speed and Performance 2VirtualScopics to Present at the 14th Annual BIO CEO & Investor Conference 2
(Date:7/26/2014)... According to the Banish My Bumps ... comprehensive guide that covers detailed instructions on how to ... need of any medication. , Vkool reveals in ... safe remedies for relieving symptoms of keratosis pilaris quickly. ...     How to treat children's keratosis pilaris , ...
(Date:7/25/2014)... Staffordshire, UK (PRWEB) July 26, 2014 ... a variety of dental services including general dentistry, clear ... practice opening in September this year in Derby. The ... is at the HollyBrook Medical Centre in Littleover, Derby. ... the new practice. , The new dental practice, which ...
(Date:7/25/2014)... In recent years, men have become more ... the symptoms associated with age-related testosterone decline. Amid concerns about ... new case study from Renew Man helps to ... using bioidentical hormones. , The case study centers around ... found himself beginning to feel the effects of age-related hormonal ...
(Date:7/25/2014)... July 25, 2014 As reported by the ... War On Heroin (7/20), police in Salem, MA as ... down on the recent heroin epidemic that has taken many ... on one heroin-related overdose case in which police were able ... victim's cell phone. By pretending to be the victim and ...
(Date:7/25/2014)... 2014 (HealthDay News) -- Seniors are more easily distracted ... new study finds. "Almost any type of memory ... age of 25 on," study co-author Randi Martin, professor ... news release. However, Martin said, this study shows ... in older adults compared with younger adults. The ...
Breaking Medicine News(10 mins):Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 3Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:Multiple States Crack Down on Heroin Epidemic 2Health News:Distractions Seem More Troublesome With Age 2
... made from some of the same parts used in ... way to measure the growth and drug susceptibility of ... The new biosensor promises to speed treatment of ... Smalley Distinguished University Professor of Chemistry, Physics and Applied ...
... Thea Friedman, M.D., associate scientist and director of ... at Hackensack University Medical Center was recently awarded a ... RO1 research grant to improve allogeneic blood and marrow ... $2 million in funding over the next five years. ...
... a successful Phase 1 study for safety, researchers at ... today announced the beginning of a Phase 2 clinical ... they developed to prevent hepatitis C virus (HCV) ... The first patients were enrolled in the study in ...
... - A recent study by Merikangas and colleagues published ... of the American Academy of Child and Adolescent Psychiatry ... are affected with severely impairing mental disorders ever receive ... that approximately one third of adolescents with any mental ...
... researchers have used a type of brain scanning, known as ... in blood flow in the brain and to correlate this ... data, which could improve is reported in the International ... have known since the 1890s that changes in blood flow ...
... risk factors for breast cancer are well studied and documented. ... period, late onset of menopause and a family history of ... However, neither an individual woman nor medicine can influence ... menopause starts - these are risk factors on which we ...
Cached Medicine News:Health News:See how they grow: Monitoring single bacteria without a microscope 2Health News:See how they grow: Monitoring single bacteria without a microscope 3Health News:Oncology basic research director at John Theurer Cancer Center continues transplantation research 2Health News:First liver transplant patients receive experimental drug to prevent hepatitis C infection 2Health News:First liver transplant patients receive experimental drug to prevent hepatitis C infection 3Health News:Adolescents with severe mental disorders have never received treatment 2Health News:Functional boost for magnetic resonance imaging 2Health News:Scientists identify avoidable breast cancer risk factors 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: